Ultra-rapid somatic variant detection via real-time targeted amplicon sequencing.
Jack WaddenBrandon S NewellJoshua BugbeeVishal JohnAmy K BruzekRobert P DicksonCarl KoschmannDavid BlaauwSatish NarayanasamyReetuparna DasPublished in: Communications biology (2022)
Molecular markers are essential for cancer diagnosis, clinical trial enrollment, and some surgical decision making, motivating ultra-rapid, intraoperative variant detection. Sequencing-based detection is considered the gold standard approach, but typically takes hours to perform due to time-consuming DNA extraction, targeted amplification, and library preparation times. In this work, we present a proof-of-principle approach for sub-1 hour targeted variant detection using real-time DNA sequencers. By modifying existing protocols, optimizing for diagnostic time-to-result, we demonstrate confirmation of a hot-spot mutation from tumor tissue in ~52 minutes. To further reduce time, we explore rapid, targeted Loop-mediated Isothermal Amplification (LAMP) and design a bioinformatics tool-LAMPrey-to process sequenced LAMP product. LAMPrey's concatemer aware alignment algorithm is designed to maximize recovery of diagnostically relevant information leading to a more rapid detection versus standard read alignment approaches. Using LAMPrey, we demonstrate confirmation of a hot-spot mutation (250x support) from tumor tissue in less than 30 minutes.
Keyphrases
- loop mediated isothermal amplification
- sensitive detection
- clinical trial
- single molecule
- cancer therapy
- decision making
- high resolution
- randomized controlled trial
- healthcare
- squamous cell carcinoma
- single cell
- quantum dots
- mass spectrometry
- cell free
- dna methylation
- gene expression
- open label
- papillary thyroid
- circulating tumor cells